Methods and systems for generating a sterilized human milk product
OwnerGlenn W. Snow, Rachelle J. Snowinventors
Life of this patent
Estimating the term…
Abstract
Systems and methods for generating a sterilized human milk product from raw human milk, and sterilized human milk product compositions obtained thereby, are provided. The method includes sterilizing the milk using a countercurrent heating process. The temperature of the milk is raised to a target temperature for a duration of time that is refined to provide a sterilized human milk product with low overall bioburden while also maintaining nutritional quality. As such, the sterilized milk product is suitable for ingestion by premature infants.
Claims19
1-30. (canceled)
A sterilized human milk product, comprising:
- human lactoferrin, at a concentration that is 81% or greater of the average concentration of lactoferrin in raw human milk;
- and
- human immunoglobulin A (IgA), at a concentration that is 73% or greater of the average concentration of IgA in raw human milk,
- wherein the sterilized human milk product has a bacterial aerobic plate count of less than 10 CFUs per gram of the sterilized human milk product.
The sterilized human milk product of claim 32, wherein the sterilized human milk product comprises less than 10% of pathogens of the average amount of pathogens in raw human milk.
The sterilized human milk product of claim 14, wherein the amino acids are in form of L-isomer.
A sterilized human milk product, wherein the product has, per 100 milliliters:
- (a) 1.0 to 2.1 grams of protein,
- (b) 0.081 grams to 1.328 grams of human lactoferrin;
- (c) at least 0.268 grams of human lactalbumin;
- (d) 63 to 67 calories,
- (e) 30 to 34 calories from fat,
- (f) 1.2 to 1.8 grams of saturated fat,
- (g) 10 to 16 mg of cholesterol,
- (h) 10 to 20 mg of sodium,
- (i) 4 to 10 grams of total carbohydrate,
- (j) 4 to 7 grams of sugars,
- (k) 160 to 200 International Units of vitamin A, and
- (l) 27 to 35 mg of calcium,
- wherein the sterilized human milk product has:
- a bacterial aerobic plate count of less than 10 CFUs per gram of the sterilized human milk product;
- a concentration of Bacillus cereus spores that is at least 10-fold lower than the average concentration of Bacillus cereus in raw human milk;
- and
- a concentration of Clostridium botulinum spores that is at least 100-fold lower than the average concentration of Clostridium botulinum in raw human milk.
Dependencies are inferred from the claim text.